```html

Gross Hematuria – A Complete Patient‑Focused Guide

Overview

Gross hematuria (also called macroscopic hematuria) is the presence of visible blood in the urine. Unlike microscopic hematuria, which can only be detected with a lab test, gross hematuria makes the urine appear pink, red, brown, or cola‑colored. It is a symptom—not a disease—signaling that something is affecting the urinary tract, which includes the kidneys, ureters, bladder, prostate (in men), and urethra.

Who it affects: Gross hematuria can occur at any age, but the underlying causes differ by age group.

• Children & adolescents: Congenital anomalies, urinary tract infections (UTIs), or kidney stones.
• Adults (20‑50 years): Kidney stones, vigorous exercise, or bladder irritation.
• Seniors (>60 years): Malignancies (bladder, kidney, prostate), chronic kidney disease, and anticoagulant use.

Prevalence: In the United States, visible hematuria accounts for roughly 1–2 % of all emergency department (ED) visits for urinary complaints. Population‑based studies estimate that about 4–5 % of adults will experience at least one episode of gross hematuria in their lifetime, with a higher incidence in men (≈60 %) because of prostate disease and bladder cancer risk [1][2].

Symptoms

Gross hematuria is usually obvious because of the color change, but it often appears alongside other urinary or systemic symptoms that help pinpoint the cause.

Primary symptom

• Discolored urine: Pink, red, brown, or tea‑colored urine. The hue may vary with the amount of blood and the time urine stays in the bladder.

Associated urinary symptoms

• Painful urination (dysuria): Burning or stinging sensation.
• Frequent urination or urgency: Often a sign of bladder irritation or infection.
• Flank or abdominal pain: Suggests kidney stones or infection of the upper urinary tract.
• Cloudy or foul‑smelling urine: Typical of infection.
• Difficulty starting or stopping urine flow (men): May signal prostate enlargement or cancer.

Systemic symptoms

• Fever or chills: Indicates infection or, less commonly, serious inflammation.
• Weight loss, night sweats, fatigue: Red flags for malignancy.
• Blood clots in urine: Large amounts of bleeding, often from tumors or severe trauma.

Causes and Risk Factors

Common causes

• Kidney stones: Abrasive edges damage urothelium, causing bleeding.
• Urinary tract infection (UTI): Bacterial invasion inflames the bladder or kidneys.
• Bladder or kidney cancer: Tumor friability leads to intermittent bleeding.
• Benign prostatic hyperplasia (BPH) and prostate cancer (men): Enlarged or malignant tissue can ulcerate.
• Trauma: Direct injury to kidneys, bladder, or urethra.
• Exercise‑induced hematuria: Prolonged or high‑impact activities (e.g., marathon running) cause microscopic trauma.
• Glomerulonephritis: Inflammation of kidney filtering units can produce visible blood.
• Polycystic kidney disease (PKD): Cysts rupture, spilling blood into urine.

Less common but serious causes

• Inherited clotting disorders (e.g., hemophilia, von Willebrand disease)
• Systemic vasculitis (e.g., ANCA‑associated vasculitis)
• Renal artery aneurysm or fistula

Risk factors

• Age: Risk of malignancy rises sharply after age 50.
• Sex: Men have higher rates of prostate‑related bleeding.
• Smoking: Increases bladder and kidney cancer risk by up to 3‑fold.
• Occupational exposure: Aromatic amines, dyes, and petroleum products.
• Chronic anticoagulant or antiplatelet therapy: Warfarin, DOACs, aspirin, clopidogrel.
• History of kidney stones or recurrent UTIs.
• Family history of kidney disease or urinary tract cancers.

Diagnosis

Because gross hematuria signals a possible serious underlying condition, a systematic work‑up is essential.

Initial evaluation

• History & physical exam: Assess onset, duration, associated pain, trauma, medication list, and risk factors.
• Urinalysis with microscopy: Confirms presence of red blood cells (RBCs), assesses for RBC casts (suggesting glomerular origin), and screens for infection, crystals, or protein.
• Complete blood count (CBC): Detects anemia from chronic blood loss.
• Serum creatinine & electrolytes: Baseline kidney function.

Imaging studies

• Ultrasound (renal & bladder): First‑line, especially in pregnant patients; identifies stones, masses, or hydronephrosis.
• Non‑contrast computed tomography (CT) scan: Gold standard for detecting urolithiasis; provides detailed anatomy for masses.
• CT urography: Offers high‑resolution images of the entire urinary tract; preferred when cancer is suspected.
• Magnetic resonance urography (MRU): Alternative for patients with contrast allergy or renal insufficiency.
• Intravenous pyelogram (IVP): Rarely used today but may be employed in low‑resource settings.

Endoscopic evaluation

• Cystoscopy: Direct visualization of the bladder and urethra; essential for diagnosing bladder tumors or stones.
• Ureteroscopy: Allows inspection and possible treatment of upper urinary tract lesions.

Specialized tests

• Urine cytology: Detects malignant cells, especially useful for carcinoma in situ.
• Kidney biopsy: Reserved for suspected glomerulonephritis or unexplained renal parenchymal disease.

Treatment Options

Treatment is directed at the underlying cause; supportive care addresses the bleeding itself.

General measures

• Hydration: Aim for ≥2 L of fluid daily (unless contraindicated) to dilute urine and promote stone passage.
• Stop anticoagulants temporarily: Under physician guidance; reversal agents (e.g., vitamin K, idarucizumab) may be needed.
• Pain control: Acetaminophen or NSAIDs (if renal function permits). Avoid aspirin if bleeding is active.

Cause‑specific therapies

Kidney stones

• Medical expulsive therapy: Alpha‑blockers (tamsulosin) facilitate stone passage for stones ≤10 mm.
• Extracorporeal shock wave lithotripsy (ESWL): Non‑invasive fragmentation.
• Ureteroscopy with laser lithotripsy: Preferred for distal stones.
• Percutaneous nephrolithotomy (PCNL): For large (>2 cm) or complex stones.

Urinary tract infection

• Empiric antibiotics based on local resistance patterns (e.g., nitrofurantoin, trimethoprim‑sulfamethoxazole, or fluoroquinolones). Adjust per culture results.

Bladder, kidney, or prostate cancer

• Transurethral resection of bladder tumor (TURBT): Diagnostic and therapeutic for non‑muscle‑invasive disease.
• Radical nephrectomy or partial nephrectomy: For localized renal cell carcinoma.
• Prostatectomy, radiation, or hormonal therapy: For prostate cancer.
• Intravesical immunotherapy (BCG) or chemotherapy: For high‑risk non‑muscle‑invasive bladder cancer.

Benign prostatic hyperplasia (BPH)

• Alpha‑blockers (tamsulosin, terazosin) to improve urinary flow.
• 5‑alpha‑reductase inhibitors (finasteride, dutasteride) to shrink prostate over months.
• Transurethral resection of the prostate (TURP) or newer minimally invasive techniques for refractory cases.

Glomerulonephritis

• Immunosuppressive therapy (corticosteroids, cyclophosphamide, rituximab) tailored to the specific pathology.
• Control of blood pressure with ACE inhibitors or ARBs.

Trauma

• Observation for minor contusions; surgical repair or embolization for major vascular injury.

Living with Gross Hematuria

Even after the acute episode resolves, many patients need ongoing strategies to monitor health and prevent recurrence.

Self‑monitoring

• Track urine color daily; note any return of pink/red hue.
• Maintain a fluid diary—aim for at least 2 L of clear water per day unless restricted.
• Record any new flank or pelvic pain, urgency, or dysuria and report promptly.

Follow‑up care

• Repeat urinalysis 1–2 weeks after treatment to ensure clearance of blood.
• Imaging (ultrasound or CT) as directed—often at 3‑month intervals after stone removal or cancer treatment.
• For patients with known bladder cancer, cystoscopy surveillance is recommended every 3–12 months depending on stage (per AUA guidelines).

Lifestyle adjustments

• Dietary modifications for stone prevention: Reduce sodium, limit animal protein, maintain adequate calcium (400–600 mg daily), and increase citrate‑rich foods (citrus fruits).
• Smoking cessation: Lowers risk of bladder and kidney cancer.
• Regular exercise: Improves overall metabolic health but avoid extreme endurance activities that provoke hematuria without adequate hydration.
• Medication review: Discuss with your clinician any over‑the‑counter NSAIDs, herbal supplements, or anticoagulants that could increase bleeding risk.

Prevention

While not all causes are preventable, many risk factors can be mitigated.

• Stay well‑hydrated: Aim for urine output >1 L/day to prevent stone formation.
• Adopt a balanced diet: Limit excess salt and oxalate‑rich foods (spinach, nuts) if you have a history of calcium oxalate stones.
• Quit smoking and limit alcohol: Reduces carcinogenic exposure.
• Maintain a healthy weight: Obesity correlates with higher risk of kidney stones and cancer.
• Use protective gear: For contact sports or high‑risk occupations to avoid blunt trauma.
• Regular medical check‑ups: Annual urinalysis for high‑risk individuals (e.g., smokers >50 y, chronic anticoagulation users).

Complications

If the underlying source of gross hematuria is not identified or treated, several serious sequelae may develop.

• Anemia: Chronic blood loss can lead to iron‑deficiency anemia, fatigue, and reduced exercise tolerance.
• Urinary obstruction: Large clots, stones, or tumor growth can block the ureter or urethra, causing hydronephrosis and renal impairment.
• Infection: Stagnant blood serves as a medium for bacterial growth, increasing risk of pyelonephritis or sepsis.
• Progression of malignancy: Delayed diagnosis of bladder, kidney, or prostate cancer reduces curative treatment options and worsens survival.
• Chronic kidney disease (CKD): Recurrent bleeding or obstructive episodes can cause irreversible loss of renal function.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Hematuria (blood in urine).” Accessed May 2026.
2. American Urological Association. “Guideline for the Management of Benign Prostatic Hyperplasia.” 2023.
3. National Cancer Institute. “Bladder Cancer Statistics.” 2024.
4. U.S. Centers for Disease Control and Prevention. “Kidney Stones.” Updated 2025.
5. Cleveland Clinic. “Kidney Stones – Causes, Symptoms, Treatment.” 2024.
6. World Health Organization. “Tobacco and Cancer.” 2023.

```